Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors is a research paper published in Annals of Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
Grant: 1U01 CA180964
National Institutes of Health
Grant: P30 CA016672
National Institutes of Health
Grant: R01CA242845
National Institutes of Health
Grant: R01CA273168
Cancer Prevention and Research Institute of Texas
Grant: RP1100584
Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
Grant: UL1 TR000371
NCI NIH HHS
Grant: U01 CA180964
University of Texas MD Anderson Cancer Center
National Center for Advancing Translational Sciences
FWCI
1.68
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals